Treatment Indications: correction of moderate facial wrinkles and folds (including nasolabial folds, marionette lines),, restoration of midface volume, contouring of cheekbones and jawline,, , improvement of facial symmetry and structural definition in the mid and lower third of the face.
Release form: 1 × 1.0 mL pre‑filled syringe
Compound: cross‑linked hyaluronic acid (non‑animal origin, produced via biofermentation), lidocaine hydrochloride, phosphate‑buffered saline solution.
Concentration of GC: 20 mg/mL
Lidocaine: 0.3%
Indications: volumization and structural contouring requiring a medium‑density,, cohesive gel with balanced viscoelastic properties (moderate G’);, correction of volume loss in the malar and submalar regions,, refinement of facial angles and borders where a stable, non‑migratory gel is required.